Cryosite (ASX:CTE) Interest Expense : A$-0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Cryosite Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cryosite's interest expense for the six months ended in Dec. 2023 was A$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cryosite's Operating Income for the six months ended in Dec. 2023 was A$ 0.93 Mil. Cryosite's Interest Expense for the six months ended in Dec. 2023 was A$ -0.01 Mil. Cryosite's Interest Coverage for the quarter that ended in Dec. 2023 was 77.83. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cryosite Interest Expense Historical Data

The historical data trend for Cryosite's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Interest Expense Chart

Cryosite Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.03

Cryosite Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.04	0.01	-0.04	0.01	-0.01

Cryosite Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00 Mil.

Cryosite (ASX:CTE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cryosite's Interest Expense for the six months ended in Dec. 2023 was A$-0.01 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$0.93 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$2.36 Mil.

Cryosite's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	0.934	/	-0.012
	=	77.83

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Cryosite Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Cryosite (ASX:CTE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142

Website

https://www.cryosite.com

Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines